Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alfred Mueck"'
Autor:
Guiju Cai, Yuejiao Wang, Tahiri Houda, Chun Yang, Lijuan Wang, Muqing Gu, Alfred Mueck, Stephane Croteau, Xiangyan Ruan, Pierre Hardy
Publikováno v:
Translational Oncology, Vol 14, Iss 6, Pp 101068- (2021)
Background: Research suggests that hormone replacement therapy may increase the risk of breast cancer, and progestins such as norethisterone (NET) play a key role in this phenomenon. We have demonstrated that microRNA-181a (miR-181a) suppresses NET-p
Externí odkaz:
https://doaj.org/article/a6dd92f65d5242c2a9fb3d39964ec61d
Autor:
Panagiotis Anagnostis, Sarantis Livadas, Dimitrios G. Goulis, Silvia Bretz, Iuliana Ceausu, Fatih Durmusoglu, Risto Erkkola, Ivan Fistonic, Marco Gambacciani, Marije Geukes, Haitham Hamoda, Caoimhe Hartley, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolas Mendoza, Alfred Mueck, Antonina Smetnik, Petra Stute, Mick van Trotsenburg, Margaret Rees, Irene Lambrinoudaki
Publikováno v:
Maturitas. 169
INTRODUCTION There is increasing evidence that vitamin D has widespread tissue effects. In addition to osteoporosis, vitamin D deficiency has been associated with cardiovascular disease, diabetes, cancer, infections and neurodegenerative disease. How
Autor:
Irene Lambrinoudaki, Eleni Armeni, Dimitrios Goulis, Silvia Bretz, Iuliana Ceausu, Fatih Durmusoglu, Risto Erkkola, Ivan Fistonic, Marco Gambacciani, Marije Geukes, Haitham Hamoda, Caiomhe Hartley, Angelica Lindén Hirschberg, Blazej Meczekalski, Nicolas Mendoza, Alfred Mueck, Antonina Smetnik, Petra Stute, Mick van Trotsenburg, Margaret Rees
Publikováno v:
Maturitas. 163
This care pathway from the European Menopause and Andropause Society (EMAS) provides an updated pathway for monitoring and guidance of women at midlife, focusing on those approaching the end of the reproductive life-cycle, going through the menopausa
Publikováno v:
Gynecological Endocrinology. :1-5
Autor:
Alfred Mueck
Publikováno v:
Zeitschrift für Orthomolekulare Medizin. 4:18-21
Autor:
Joseph, Neulen, Christian, Thaler, Martin, Birkhäuser, Wilhelm, Braendle, Paul J, Keller, Ludwig, Kiesel, Herbert, Kuhl, Alfred, Mueck
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 66(2)
The risk-benefit-ratio of hormonal contraception (OC) is positive in adolescents as well as in women over 40 years of age if some essential rules are respected. In adolescents, the acquirement of a normal peak bone mass has to be guaranteed by the us
Autor:
Christian, Thaler, Herbert, Kuhl, Alfred, Mueck, Martin, Birkhäuser, Wilhelm, Braendle, Joseph, Neulen, Paul J, Keller, Ludwig, Kiesel
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 66(2)
Since the correlation between the amount of Ethinylestradiol (EE) and the thromboembolic risk has been recognized, the development of new oral contraceptives (OC) has been characterized by a constant lowering of the EE dosage. The consecutive decreas
Autor:
Herbert, Kuhl, Martin, Birkhäuser, Alfred, Mueck, Joseph, Neulen, Christian, Thaler, Ludwig, Kiesel, Wilhelm, Braendle
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 66(2)
Surveys show that most women desire a change in their menstrual pattern in the sense that they would prefer less menstruations or even amenorrhea. On this behalf, there is no difference between women having spontaneous natural cycles and women taking
Autor:
Wilhelm, Braendle, Herbert, Kuhl, Alfred, Mueck, Martin, Birkhäuser, Christian, Thaler, Ludwig, Kiesel, Joseph, Neulen
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 66(2)
A non-contraceptive benefit of oral hormonal contraceptives (OC) is a diminished risk for certain benign as well as malignant tumours, such as benign breast tumours, uterine fibroids and ovarian cysts. Endometriosis itself is not positively influence
Autor:
Alfred, Mueck, Joseph, Neulen, Christian, Thaler, Martin, Birkhäuser, Wilhelm, Braendle, Ludwig, Kiesel, Herbert, Kuhl
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 66(2)
Thromboembolic, cardiovascular and cerebrovascular events are age-dependent. They are extremely rare in young women. In contrast to the progestogen-only pills, oral contraceptives (OC) increase the risk of venous thrombosis. However, decisive ist the